Share:
Bill Information - History
Senate Bill 675; Regular Session 2019-2020
Printer's No.(PN):
820*
Short Title:
An Act providing for certification of buprenorphine office-based prescribers; limiting the use of buprenorphine; and imposing powers and duties on the Department of Drug and Alcohol Programs.
Actions:
| PN 0820 | Referred to HEALTH AND HUMAN SERVICES, May 28, 2019 |
|
Reported as committed, June 4, 2019 |
||
Re-referred to APPROPRIATIONS, June 5, 2019 |
||
Re-reported as committed, June 10, 2019 |
||
Third consideration and final passage, June 17, 2019 (41-9) |
||
In the House |
||
Referred to HUMAN SERVICES, June 18, 2019 |
* denotes current Printer's Number